TrialJournal of thrombosis and thrombolysis2020

Associations between model-predicted rivaroxaban exposure and patient characteristics and efficacy and safety outcomes in the prevention of venous thromboembolism.

Isabel Reinecke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.